1. Home
  2. SSMR vs KLRA Comparison

SSMR vs KLRA Comparison

Compare SSMR & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Silver Mining & Refining Company Common Stock

SSMR

Sunshine Silver Mining & Refining Company Common Stock

N/A

Current Price

$11.02

Market Cap

1.9B

ML Signal

N/A

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$11.37

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSMR
KLRA
Founded
2010
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2026
2026

Fundamental Metrics

Financial Performance
Metric
SSMR
KLRA
Price
$11.02
$11.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$19.08
★ $43.00
AVG Volume (30 Days)
★ 1.1M
747.0K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.63
$9.76
52 Week High
$19.61
$23.82

Technical Indicators

Market Signals
Indicator
SSMR
KLRA
Relative Strength Index (RSI) 37.63 39.32
Support Level $11.00 $9.76
Resistance Level $15.17 $11.81
Average True Range (ATR) 1.12 0.98
MACD -0.09 -0.22
Stochastic Oscillator 11.96 4.61

Price Performance

Historical Comparison
SSMR
KLRA

About SSMR Sunshine Silver Mining & Refining Company Common Stock

Sunshine Silver Mining & Refining Co is a mining exploration and development company. It owns and develops the Sunshine Mine, the Sunshine Silver/Copper Refinery, and related facilities, including the Sunshine Tailings Storage Facility and historical antimony refinery grounds. The Sunshine Mine is a permitted past-producing silver mine in the United States that has historically produced silver, antimony, copper, and lead.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: